Rhythm Pharmaceuticals, Inc. Gains 24.35%
Fri, Jul 15, 2022 at 08:21 PM
Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) soared at $10.01, representing a gain of 24.3%. On Fri, Jul 15, 2022, RYTM:NASDAQ touched a New 2-Week High of $10.01. The stock got featured on our News Catalysts scanner on Wed, Jul 13, 2022 at 02:39 PM in the 'MISCELLANEOUS' category. From Fri, Jul 01, 2022, the stock recorded 77.78% Up Days and 80.00% Green Days
About Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ)
Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
Top 10 Gainers:
- United Maritime Corporation (USEA:NASDAQ), 175.91%
- Vertical Aerospace Ltd. (EVTL:NYSE), 72.41%
- ITHAX Acquisition Corp. (ITHX:NASDAQ), 40.6%
- Nymox Pharmaceutical Corporation (NYMX:NASDAQ), 38.89%
- Vigil Neuroscience Inc. (VIGL:NASDAQ), 31.56%
- Cemtrex, Inc. (CETX:NASDAQ), 30.71%
- Auddia Inc. (AUUD:NASDAQ), 30%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 28.3%
- NexImmune Inc. (NEXI:NASDAQ), 24.49%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 24.35%